Status:
RECRUITING
Medical Follow-up of New Cases of Polyarthritis in Children and Young Adults
Lead Sponsor:
Université Catholique de Louvain
Conditions:
Juvenile Idiopathic Arthritis
Rheumatoid Arthritis
Eligibility:
All Genders
2-50 years
Brief Summary
Population: Juvenile idiopathic arthritis (JIA), rheumatoid arthritis (RA) and seronegative / psoriatic / undifferentiated arthritis (UA), systemic lupus erythematosus (SLE) or diffuse systemic scler...
Detailed Description
This study is proposed by the Rheumatology and Pediatrics departments of the 3 French-speaking Universities. The first objective will be to include a progressive number of new young patients (≤ 50 ye...
Eligibility Criteria
Inclusion
- Diagnosis of juvenile idiopathic arthritis, rheumatoid arthritis and seronegative / psoriatic / undifferentiated arthritis, systemic lupus erythematosus or diffuse systemic sclerosis (ACR criteria).
- Naïve to basic treatment OR treated for ≤ 3 months; except for patients with JIA.
Exclusion
- Treated for \> 3 months
- \> 50 years old
Key Trial Info
Start Date :
September 11 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 31 2028
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT07000916
Start Date
September 11 2013
End Date
March 31 2028
Last Update
June 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCLouvain
Brussels, Belgium, 1200